Wells Fargo’s Cyclerion Therapeutics CYCN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $48 | Hold |
|
|||||
|
2023
Q4 | $50 | Buy |
|
|||||
|
2023
Q3 | $48 | Hold |
|
|||||
|
2023
Q2 | $58 | Hold |
|
|||||
|
2023
Q1 | $118 | Sell |
|
|||||
|
2022
Q4 | $1.55K | Buy |
|
|||||
|
2022
Q3 | $0 | Sell |
|
|||||
|
2022
Q2 | $0 | Buy |
|
|||||
|
2022
Q1 | $0 | Hold |
|
|||||
|
2021
Q4 | $0 | Hold |
|
|||||
|
2021
Q3 | $1K | Buy |
|
|||||
|
2021
Q2 | $1K | Sell |
|
|||||
|
2021
Q1 | $21K | Sell |
|
|||||
|
2020
Q4 | $154K | Buy |
|
|||||
|
2020
Q3 | $173K | Sell |
|
|||||
|
2020
Q2 | $205K | Sell |
|
|||||
|
2020
Q1 | $145K | Buy |
|
|||||
|
2019
Q4 | $118K | Sell |
|
|||||
|
2019
Q3 | $722K | Buy |
|
|||||
|
2019
Q2 | $408K | Buy |
|